Newgen Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 82.34%
(FY 2021)
- Profit 123.23%
(FY 2021)
- Ebitda 29.74%
(FY 2021)
- Net Worth 43.26%
(FY 2021)
- Total Assets 6.77%
(FY 2021)
About Newgen Bioscience
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandran Bakthavachalam and Panchamirtham serve as directors at the Company.
- CIN/LLPIN
U24100PY2010PTC002466
- Company No.
002466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Newgen Bioscience Private Limited offer?
Newgen Bioscience Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Micronutrient Fertilizers, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Healthcare Products & Aids, Health Drinks, Feed Additives.
Who are the key members and board of directors at Newgen Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandran Bakthavachalam  | Director | 18-Jun-2010 | Current |
| Panchamirtham | Director | 05-May-2021 | Current |
Financial Performance of Newgen Bioscience.
Newgen Bioscience Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 82.34% increase. The company also saw a substantial improvement in profitability, with a 123.23% increase in profit. The company's net worth Soared by an impressive increase of 43.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newgen Bioscience?
In 2021, Newgen Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Newgen Bioscience?
Unlock and access historical data on people associated with Newgen Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newgen Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newgen Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
